20
Participants
Start Date
December 31, 2017
Primary Completion Date
February 21, 2020
Study Completion Date
January 31, 2021
Ultraflux® EMiC®2
Ultraflux® EMiC®2-CVVHD runs in septic shock patients with AKI KDIGO 3 for 24 hours. and patients were randomised to start Ultraflux® EMiC®2-CVVHD in the first day or in the second day from the RRT start; more precisely, crossover randomized to sequence consists in Ultraflux® EMiC®2-CVVHD (first day)+ HFF-CVVHDF(second day) and HFF-CVVHDF (first day) + Ultraflux® EMiC®2-CVVHD (second day) for 48 h total without washout
Fiorenza Ferrari, Pavia
International Renal Research Institute Vicenza
OTHER
University of Giessen
OTHER
Fiorenza Ferrari
OTHER